CE-certified AI-powered benchtop platform automating 3D tissue selection and transfer for scalable drug discovery
Alzheimer’s disease
Xemperia flag-ship project is a PCR-based blood test for breast cancer screening.The technology can be adapted to other cancers, immune, inflammatory and cardiovascular diseases.Xemperia's pipeline also includes DNA based nansensors for the ultrasensitive detection of nucleic acids.